Neonatal abstinence syndrome, maternal opioid-related diagnoses up

Lipid biomarkers in urine can determine the type of asthma
13 January 2021
Nanotechnology prevents premature birth in mouse studies
13 January 2021

Neonatal abstinence syndrome, maternal opioid-related diagnoses up

(HealthDay)—From 2010 to 2017, there were significant increases in the estimated rates of neonatal abstinence syndrome (NAS) and maternal opioid-related diagnoses (MOD), according to a study published in the Jan. 12 issue of the Journal of the American Medical Association.

Comments are closed.